Literature DB >> 9528899

Cytomegalovirus (CMV) infection in AIDS patients is associated with a CD3 receptor-mediated T cell hyporesponsiveness.

A W Rowbottom1, M W Lepper, D Sharpstone, B Gazzard.   

Abstract

HIV+ individuals with human CMV (HCMV) reactivation have a CD3 receptor-mediated T cell hyporesponsiveness when compared with CD4-matched HIV+ and HCMV- control groups. The impairment of proliferation was not reversed by exogenous IL-2. A typical increase in NFkappaB expression was observed following cross-linking of the CD3 receptor, but did not lead to increased CD25 cell surface expression or cell proliferation. The HCMV-induced non-responsiveness was not observed when cells were stimulated with phorbol esters. Lymphocytes cultured with media collected from cell cultures infected with HCMV showed a dose-dependent inhibition in the total T cell population even though cells staining dually for CD8/57 increased in number. The altered growth factor requirements of CD8/57+ cells may therefore account for their presence in AIDS and patients following bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528899      PMCID: PMC1904875          DOI: 10.1046/j.1365-2249.1998.00515.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.

Authors:  J A Ledbetter; C H June; P J Martin; C E Spooner; J A Hansen; K E Meier
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

2.  Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus.

Authors:  R D Schrier; G P Rice; M B Oldstone
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

Review 3.  Cytomegalovirus-induced immunosuppression.

Authors:  M S Hirsch; D Felsenstein
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

4.  Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.

Authors:  N J Borthwick; M Bofill; W M Gombert; A N Akbar; E Medina; K Sagawa; M C Lipman; M A Johnson; G Janossy
Journal:  AIDS       Date:  1994-04       Impact factor: 4.177

5.  An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

Authors:  S C Meuer; R E Hussey; M Fabbi; D Fox; O Acuto; K A Fitzgerald; J C Hodgdon; J P Protentis; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

6.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

Review 7.  Models of T cell anergy: is there a common molecular mechanism?

Authors:  R H Schwartz
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

8.  CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus.

Authors:  E C Wang; P A Moss; P Frodsham; P J Lehner; J I Bell; L K Borysiewicz
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

9.  Cytomegalovirus colitis in HIV-1-infected patients: a prospective research in 55 patients.

Authors:  H Mentec; C Leport; J Leport; C Marche; M Harzic; J L Vildé
Journal:  AIDS       Date:  1994-04       Impact factor: 4.177

10.  A primary T-cell immunodeficiency associated with defective transmembrane calcium influx.

Authors:  F Le Deist; C Hivroz; M Partiseti; C Thomas; H A Buc; M Oleastro; B Belohradsky; D Choquet; A Fischer
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.